Latest News
Media Releases, News Items & More
DENOZA® is now available in Canada
Latest News DENOZA® (denosumab injection), a biosimilar from Apotex, is now available in Canada September 25, 2026 PrDENOZA® is indicated for the treatment of postmenopausal osteoporosis, and to increase bone […]
Healthcare Professional Educational Events
Healthcare Professional Educational Events August 19, 2026 View the following information for two events for the healthcare professional: Canadian Symposia on Rare Bone Diseases 2026 ISCD Quality Bone Densitometry: for […]
Researchers Use Machine Learning To Better Predict Fractures Caused By Weak Bones
Latest News Researchers Use Machine Learning To Better Predict Fractures Caused By Weak Bones July 7, 2026 Fragility fractures are a major and growing health burden, with significant personal and […]
INESSS in Quebec has issued a recommendation to transfer denosumab from the Exceptional Drugs section to the Regular section
Latest News INESSS in Quebec has issued a recommendation to transfer denosumab from the Exceptional Drugs section to the Regular section June 23, 2026 INESSS (the Institut national d’excellence en […]
Health Canada Approves of DENOZA™, a Denosumab Biosimilar
Latest News Health Canada Approves of DENOZA™, a Denosumab Biosimilar May 5, 2026 Apotex Inc., a Canadian based global pharmaceutical company announced that Health Canada has approved DENOZA™ (denosumab injection), […]
Positive Outcome for BMD Testing in Ontario
Latest News Positive Outcome for BMD Testing in Ontario April 30, 2026 At Osteoporosis Canada, we are aware that the April 1, 2026 updates to the Schedule of Benefits included […]
Changes in BMD testing in Ontario – An Update
April 24, 2026 Contributors: Dr. Adrian Lau, Dr. Heather McDonald-Blumer, Dr. Laëtitia Michou, Dr. Claudia Gagnon, Dr. Zahra Bardai , Dr. Vithika Sivabalasundaram, Sarah Rydahl, Dr. Shirine Usmani, As of April […]
Changes in BMD Testing in Ontario
April 7, 2026 Contributors: Dr. Adrian Lau, Dr. Heather McDonald-Blumer, Dr. Sandra Kim, Dr. Natasha Gakhal, Dr. Lianne Tile, Dr. Angela Cheung, Dr. Julie Gilmour, Dr. Laëtitia Michou, Dr. Claudia […]
FDA Qualifies First Surrogate Endpoint For Use In Osteoporosis Clinical Trials
Update On Clinical Trials FDA Qualifies First Surrogate Endpoint For Use In Osteoporosis Clinical Trials December 22, 2025 Osteoporosis Canada is excited to share the US Food and Drug Administration […]